rapamycin loaded red blood cell membrane (Dawley Inc)
86
Structured Review
Dawley Inc
rapamycin loaded red blood cell membrane
Rapamycin Loaded Red Blood Cell Membrane, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/load+cell/blood+cells+red/pmc13264409-29-0-22
Average 86 stars, based on 1 article reviews
Rapamycin Loaded Red Blood Cell Membrane, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/load+cell/blood+cells+red/pmc13264409-29-0-22
Average 86 stars, based on 1 article reviews
rapamycin loaded red blood cell membrane - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Injection:Article Title: Nanocomposite preparation apparatus Article Snippet: .. 5) Hemolysis (1) Experiment Method Blood samples were injected into male Sprague-Dawley rats and centrifuged, and then Saline:Article Title: Nanocomposite preparation apparatus Article Snippet: .. 5) Hemolysis (1) Experiment Method Blood samples were injected into male Sprague-Dawley rats and centrifuged, and then Isolation:Article Title: Maleimide-substituted 1,4-naphthoquinone flaviolin mimetic (FM 7 ) induces S-phase arrest and mitochondria-mediated apoptosis in multiple myeloma cells. Article Snippet: Cancer remains a leading cause of mortality globally and is projected to significantly impact life expectancy in the coming decades [1].. Among hematologic malignancies, multiple myeloma (MM) ranks as the second most prevalent worldwide, characterized by the clonal proliferation of malignant plasma cells within the bone marrow [2].. MM constitutes approximately 0.9% of newly diagnosed cancers and accounts for 1.1% of cancer-related deaths worldwide [3]. Article Title: M2 Macrophage-derived Exosome Nanoplatform for Targeted H 2 S Delivery to Alleviate Hepatic Ischemia-Reperfusion Injury via Synergistic Anti-Oxidative, Anti-Inflammatory, and Anti-Ferroptotic Effects. Article Snippet: Hepatic ischemia-reperfusion injury (HIRI) presents a critical challenge in liver surgery, transplantation, and trauma, driven by the interplay of oxidative stress, inflammation, and ferroptosis.. Current treatments are limited by poor targeting and insufficient efficacy.. Here, we develop a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H2S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos), enabling liver-specific H2S delivery. Gradient Centrifugation:Article Title: Maleimide-substituted 1,4-naphthoquinone flaviolin mimetic (FM 7 ) induces S-phase arrest and mitochondria-mediated apoptosis in multiple myeloma cells. Article Snippet: Cancer remains a leading cause of mortality globally and is projected to significantly impact life expectancy in the coming decades [1].. Among hematologic malignancies, multiple myeloma (MM) ranks as the second most prevalent worldwide, characterized by the clonal proliferation of malignant plasma cells within the bone marrow [2].. MM constitutes approximately 0.9% of newly diagnosed cancers and accounts for 1.1% of cancer-related deaths worldwide [3]. Centrifugation:Article Title: M2 Macrophage-derived Exosome Nanoplatform for Targeted H 2 S Delivery to Alleviate Hepatic Ischemia-Reperfusion Injury via Synergistic Anti-Oxidative, Anti-Inflammatory, and Anti-Ferroptotic Effects. Article Snippet: Hepatic ischemia-reperfusion injury (HIRI) presents a critical challenge in liver surgery, transplantation, and trauma, driven by the interplay of oxidative stress, inflammation, and ferroptosis.. Current treatments are limited by poor targeting and insufficient efficacy.. Here, we develop a liver-targeted exosomal nanoplatform (DATS@M2-Exos) by encapsulating the H2S donor diallyl trisulfide (DATS) into M2 macrophage-derived exosomes (M2-Exos), enabling liver-specific H2S delivery. Suspension:Article Title: Cascade ROS-modulating Au/Cu nanozyme hydrogel with nitric oxide release ability for accelerated diabetic foot ulcer healing. Article Snippet: Diabetic foot ulcers (DFUs) persist due to excessive reactive oxygen species (ROS), infection, and poor angiogenesis.. We engineered an injectable guar gum hydrogel (AuCu-Arg/Gel) embedding gold/copper nanozymes (Au@Cu2(OH)3Cl–L-Arg) to address these barriers synergistically.. The nanozymes display cascade-mimicking peroxidase, superoxide dismutase, and catalase activities to rebalance ROS. Produced:Article Title: Emerging biomimetic biopolymer-based composites: advancing accessible and sustainable neural disease models and therapeutics Article Snippet: .. In testing nanoparticles produced by against |